{
  "actions": [
    {
      "acted_at": "2020-05-15",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2020-05-15",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2020-05-15",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr6885-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "B001307",
      "district": "4",
      "name": "Baird, James R.",
      "original_cosponsor": false,
      "sponsored_at": "2020-07-01",
      "state": "IN",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "T000165",
      "district": "7",
      "name": "Tiffany, Thomas P.",
      "original_cosponsor": false,
      "sponsored_at": "2020-07-01",
      "state": "WI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000827",
      "district": "6",
      "name": "Wright, Ron",
      "original_cosponsor": false,
      "sponsored_at": "2020-06-18",
      "state": "TX",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-05-15",
  "number": "6885",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to prohibit the importation of a drug or device that was manufactured at a banned foreign facility, to create incentives for pharmaceutical or device companies to increase manufacturing capacity in the United States, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Safe and Secure Medicine Supply for Hardworking Americans Act of 2020",
  "sponsor": {
    "bioguide_id": "F000461",
    "district": "17",
    "name": "Flores, Bill",
    "state": "TX",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-05-15",
  "subjects": [
    "Asia",
    "China",
    "Civil actions and liability",
    "Congressional oversight",
    "Drug safety, medical device, and laboratory regulation",
    "Employment and training programs",
    "Government information and archives",
    "Government trust funds",
    "Health",
    "Health information and medical records",
    "India",
    "Manufacturing",
    "Prescription drugs",
    "Tariffs",
    "Trade restrictions"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2020-05-15",
    "date": "2021-01-28T15:13:32Z",
    "text": "Safe and Secure Medicine Supply for Hardworking Americans Act of 2020\n\nThis bill bans in certain instances the importation of drugs and medical devices from a foreign manufacturing facility that has been subject to a recall, imposes additional duties on imported drugs, and contains other related provisions.\n\nThe Food and Drug Administration shall ban drug or device imports from a foreign facility for a specified amount of time if a drug or device from that facility has been subject to a Class I or Class II recall. The bill imposes civil monetary fines for any individual or entity that violates such an import ban.\n\nThe bill also imposes, on top of any other duties, a 25% duty on drugs imported from China, a 20% duty on drugs imported from India, and a 10% duty on drugs imported from any other country.\n\nThe duties and fines established under this bill shall go into a fund for supporting and incentivizing new pharmaceutical or medical device manufacturing in the United States.\n\nThe bill also requires each drug sold to state on its label the country of origin of each active pharmaceutical ingredient."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Safe and Secure Medicine Supply for Hardworking Americans Act of 2020",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to prohibit the importation of a drug or device that was manufactured at a banned foreign facility, to create incentives for pharmaceutical or device companies to increase manufacturing capacity in the United States, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Safe and Secure Medicine Supply for Hardworking Americans Act of 2020",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:42:54Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr6885.xml"
}